VentriPoint Non Current Assets Total vs Long Term Debt Analysis

VPT Stock  CAD 0.17  0.01  5.56%   
VentriPoint Diagnostics financial indicator trend analysis is much more than just breaking down VentriPoint Diagnostics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VentriPoint Diagnostics is a good investment. Please check the relationship between VentriPoint Diagnostics Non Current Assets Total and its Long Term Debt accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Non Current Assets Total vs Long Term Debt

Non Current Assets Total vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VentriPoint Diagnostics Non Current Assets Total account and Long Term Debt. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between VentriPoint Diagnostics' Non Current Assets Total and Long Term Debt is -0.3. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of VentriPoint Diagnostics, assuming nothing else is changed. The correlation between historical values of VentriPoint Diagnostics' Non Current Assets Total and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of VentriPoint Diagnostics are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Non Current Assets Total i.e., VentriPoint Diagnostics' Non Current Assets Total and Long Term Debt go up and down completely randomly.

Correlation Coefficient

-0.3
Relationship DirectionNegative 
Relationship StrengthInsignificant

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Long Term Debt

Long-term debt is a debt that VentriPoint Diagnostics has held for over one year. Long-term debt appears on VentriPoint Diagnostics balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on VentriPoint Diagnostics balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Most indicators from VentriPoint Diagnostics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VentriPoint Diagnostics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, VentriPoint Diagnostics' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to climb to about 47.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.7 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization48.8K50.9K66.7K45.9K
Income Tax Expense92.9K136.1K3.02.85

VentriPoint Diagnostics fundamental ratios Correlations

-0.310.93-0.97-0.390.21.01.00.470.560.36-0.321.00.01-0.160.220.190.380.26-0.48-0.29-0.490.29-0.13-0.48-0.23
-0.31-0.620.450.150.24-0.34-0.34-0.09-0.440.250.93-0.310.10.31-0.39-0.4-0.41-0.280.540.620.420.11-0.320.010.27
0.93-0.62-0.97-0.390.040.930.930.410.630.15-0.650.93-0.08-0.380.310.270.460.33-0.67-0.42-0.530.190.08-0.45-0.21
-0.970.45-0.970.39-0.11-0.97-0.97-0.37-0.58-0.20.5-0.970.010.37-0.2-0.17-0.43-0.340.620.290.51-0.27-0.060.460.16
-0.390.15-0.390.39-0.69-0.36-0.36-0.66-0.88-0.210.13-0.370.510.03-0.53-0.38-0.89-0.770.560.60.82-0.540.20.750.07
0.20.240.04-0.11-0.690.170.170.370.40.370.30.19-0.050.280.07-0.010.540.55-0.14-0.52-0.540.59-0.44-0.52-0.04
1.0-0.340.93-0.97-0.360.171.00.410.540.3-0.351.00.04-0.180.180.140.370.25-0.49-0.29-0.480.26-0.09-0.44-0.24
1.0-0.340.93-0.97-0.360.171.00.410.540.3-0.351.00.03-0.180.180.150.370.25-0.49-0.29-0.480.26-0.09-0.44-0.24
0.47-0.090.41-0.37-0.660.370.410.410.780.6-0.020.45-0.510.140.730.620.530.3-0.38-0.34-0.560.35-0.5-0.7-0.17
0.56-0.440.63-0.58-0.880.40.540.540.780.27-0.380.55-0.63-0.070.750.580.890.64-0.67-0.59-0.870.4-0.22-0.71-0.21
0.360.250.15-0.2-0.210.370.30.30.60.270.350.34-0.120.380.330.330.07-0.070.05-0.04-0.250.53-0.44-0.36-0.25
-0.320.93-0.650.50.130.3-0.35-0.35-0.02-0.380.35-0.320.080.63-0.27-0.3-0.35-0.320.680.470.310.11-0.490.10.06
1.0-0.310.93-0.97-0.370.191.01.00.450.550.34-0.320.02-0.170.20.160.360.25-0.48-0.28-0.470.28-0.13-0.47-0.23
0.010.1-0.080.010.51-0.050.040.03-0.51-0.63-0.120.080.020.02-0.61-0.29-0.5-0.120.450.140.45-0.030.10.470.14
-0.160.31-0.380.370.030.28-0.18-0.180.14-0.070.380.63-0.170.020.130.07-0.04-0.230.64-0.11-0.080.04-0.60.25-0.43
0.22-0.390.31-0.2-0.530.070.180.180.730.750.33-0.270.2-0.610.130.910.580.27-0.41-0.35-0.610.21-0.2-0.43-0.21
0.19-0.40.27-0.17-0.38-0.010.140.150.620.580.33-0.30.16-0.290.070.910.420.3-0.3-0.27-0.450.25-0.12-0.3-0.11
0.38-0.410.46-0.43-0.890.540.370.370.530.890.07-0.350.36-0.5-0.040.580.420.83-0.6-0.65-0.90.56-0.08-0.47-0.14
0.26-0.280.33-0.34-0.770.550.250.250.30.64-0.07-0.320.25-0.12-0.230.270.30.83-0.5-0.51-0.70.650.01-0.370.21
-0.480.54-0.670.620.56-0.14-0.49-0.49-0.38-0.670.050.68-0.480.450.64-0.41-0.3-0.6-0.50.370.63-0.22-0.270.59-0.12
-0.290.62-0.420.290.6-0.52-0.29-0.29-0.34-0.59-0.040.47-0.280.14-0.11-0.35-0.27-0.65-0.510.370.63-0.230.10.330.26
-0.490.42-0.530.510.82-0.54-0.48-0.48-0.56-0.87-0.250.31-0.470.45-0.08-0.61-0.45-0.9-0.70.630.63-0.520.140.50.19
0.290.110.19-0.27-0.540.590.260.260.350.40.530.110.28-0.030.040.210.250.560.65-0.22-0.23-0.52-0.01-0.210.15
-0.13-0.320.08-0.060.2-0.44-0.09-0.09-0.5-0.22-0.44-0.49-0.130.1-0.6-0.2-0.12-0.080.01-0.270.10.14-0.010.320.14
-0.480.01-0.450.460.75-0.52-0.44-0.44-0.7-0.71-0.360.1-0.470.470.25-0.43-0.3-0.47-0.370.590.330.5-0.210.32-0.01
-0.230.27-0.210.160.07-0.04-0.24-0.24-0.17-0.21-0.250.06-0.230.14-0.43-0.21-0.11-0.140.21-0.120.260.190.150.14-0.01
Click cells to compare fundamentals

VentriPoint Diagnostics Account Relationship Matchups

VentriPoint Diagnostics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets314.3K801.6K9.5M6.0M1.9M2.0M
Total Current Liabilities1.9M1.8M1.1M1.1M1.4M2.1M
Total Stockholder Equity(2.5M)(2.3M)8.3M4.6M189.7K199.2K
Net Debt1.1M843.8K(9.1M)(4.7M)(1.0M)(969.0K)
Retained Earnings(37.9M)(39.9M)(43.7M)(48.6M)(53.5M)(50.8M)
Accounts Payable1.2M1.0M988.6K842.0K856.2K792.2K
Cash13.8K526.0K9.3M5.2M1.3M1.5M
Cash And Short Term Investments13.8K526.0K9.3M5.2M1.3M1.5M
Net Receivables67.7K165.3K197.5K374.2K285.5K299.8K
Common Stock Shares Outstanding63.4M74.5M136.1M156.0M156.8M164.7M
Liabilities And Stockholders Equity314.3K801.6K9.5M6.0M1.9M2.0M
Other Stockholder Equity6.0M6.4M9.8M10.4M10.9M7.5M
Total Liab2.8M3.2M1.2M1.4M1.7M2.6M
Total Current Assets176.0K714.5K9.5M5.7M1.6M1.9M
Non Current Liabilities Total868.0K1.3M125.4K367.4K297.0K468.6K
Property Plant And Equipment Net138.3K87.1K42.5K313.3K246.6K258.9K
Non Current Assets Total138.3K87.1K42.5K313.3K246.6K134.6K
Other Current Liab12.8K500.062.3K122.1K453.6K753.2K
Short Term Debt257.1K42.8K34.6K91.6K55.0K52.3K
Net Tangible Assets(1.7M)(1.0M)(2.5M)(2.3M)(2.1M)(2.2M)
Other Current Assets63.8K23.1K35.9K103.5K56.9K73.8K
Common Stock29.5M31.0M42.2M42.7M49.1M28.8M
Property Plant Equipment49.9K49.0K138.3K87.1K100.1K71.6K
Net Invested Capital(1.5M)(1.1M)8.5M4.7M327.8K311.4K
Net Working Capital(1.7M)(1.1M)8.4M4.6M240.1K228.1K
Capital Stock29.5M31.0M42.2M42.7M49.1M39.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VentriPoint Stock Analysis

When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.